Premier Destination for Sophisticated Buyers of Legal Services
Home > Legal Library > Abstract




Join Matindale-Hubbell Connected


FDA's New Transparency Task Force: Mission and Opportunity for Public Comment


by Edward M. Basile View Biography
Jennifer L. Bragg View Biography
Daniel Francis Donovan View Biography
King & Spalding LLP View Firm Credentials
Washington Office

Beverly Lorell
King & Spalding LLP View Firm Credentials
Atlanta Office

June 26, 2009

Previously published on June 12, 2009

On June 3, the U.S. Food and Drug Administration (FDA or Agency) announced the formation of the FDA Transparency Task Force (Task Force) to solicit public comments and to promulgate recommendations for enhancing the transparency of the FDA's internal activities and decision-making.


 

The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.


 

Practice Area Resource Centers
Visit our Practice Area Resource Centers to view practice area specific content compiled from a variety of legal sources. Find related articles, podcasts, industry leader insights and much more. We currently offer the following Practice Areas: Litigation; Intellectual Property; Real Estate; Corporate Law; Criminal Law; Bankruptcy; Immigration; Business Law; Insurance; Taxation; Labor & Employment; Commercial Law; Medical Malpractice; Trusts & Estates; Securities; International Law ; Health Care; Environmental Law; Construction Law; Workers' Compensation





Total Practice Solutions

 

Terms & Conditions | Privacy | Copyright 2009 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.